BioLineRx (BLRX) Free Cash Flow Growth (5y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.05% |
| Sep 30, 2025 | 17.38% |
| Jun 30, 2025 | 49.82% |
| Mar 31, 2025 | 17.40% |
| Dec 31, 2024 | -9.73% |
| Sep 30, 2024 | -9.76% |
| Jun 30, 2024 | -11.97% |
| Mar 31, 2024 | -25.12% |
| Dec 31, 2023 | 24.51% |
| Sep 30, 2023 | -10.49% |
| Jun 30, 2023 | -9.13% |
| Mar 31, 2023 | -3.41% |
| Dec 31, 2022 | 1.59% |
| Sep 30, 2022 | -6.94% |
| Jun 30, 2022 | -8.42% |
| Mar 31, 2022 | -8.24% |
| Dec 31, 2021 | -5.33% |
| Sep 30, 2021 | -10.96% |
| Jun 30, 2021 | -16.05% |
| Mar 31, 2021 | -8.94% |
| Dec 31, 2020 | -12.83% |
| Sep 30, 2020 | -13.11% |
| Jun 30, 2020 | -19.96% |
| Mar 31, 2020 | -15.21% |
| Dec 31, 2019 | -2.70% |
| Sep 30, 2019 | -14.20% |
| Jun 30, 2019 | -8.35% |
| Mar 31, 2019 | -6.54% |
| Dec 31, 2018 | -6.47% |
| Sep 30, 2018 | -6.89% |
| Jun 30, 2018 | -0.05% |
| Mar 31, 2018 | -5.17% |